Literature DB >> 23167814

Exaggerated NT-proBNP production in patients with hematologic malignancies: a case series.

Aileen Andreu1, Maya Guglin.   

Abstract

©2011 Wiley Periodicals Inc. Extremely elevated serum brain natriuretic peptide (BNP) in cancer patients is a poorly understood phenomenon. The authors report three cases of patients with hematologic malignancies and serial N-terminal pro-BNP (NT-proBNP) measurements with values in the range of tens to hundred thousands pg/mL. Through matching NT-proBNP results with clinical, laboratory, echocardiographic and radiologic data, the authors found that these patients demonstrated exaggerated responses to fluid overload. Patients with hematologic malignancies may have higher than expected values of NT-proBNP in response to hypervolemic states. The authors hypothesize that this may be related to possible infiltration of the myocardium by substances produced in the setting of these diseases or due to proteins interfering with the assay.Congest Heart Fail.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 23167814     DOI: 10.1111/j.1751-7133.2011.00258.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  4 in total

1.  N-Terminal pro-brain natriuretic peptide (NTproBNP) in patients with symptomatic multiple myeloma: report from a single institution.

Authors:  Victor H Jimenez-Zepeda; Holly Lee; Jason Tay; Peter Duggan; Sylvia McCulloch; Paola Neri; Nizar J Bahlis
Journal:  Ann Hematol       Date:  2021-07-21       Impact factor: 3.673

2.  Chemotherapy and echocardiographic indices in patients with non-Hodgkin lymphoma: the ONCO-ECHO study.

Authors:  Katarzyna Mizia-Stec; Marek Elżbieciak; Maciej T Wybraniec; Monika Różewicz; Artur Bodys; Wojciech Braksator; Zbigniew Gąsior; Piotr Gościniak; Tomasz Hryniewiecki; Jarosław Kasprzak; Andrzej Wojtarowicz; Barbara Zdziarska; Edyta Płońska-Gościniak
Journal:  Med Oncol       Date:  2017-12-22       Impact factor: 3.064

3.  Plasma brain natriuretic peptide levels are elevated in patients with cancer.

Authors:  Sachiko Bando; Takeshi Soeki; Tomomi Matsuura; Takeshi Tobiume; Takayuki Ise; Kenya Kusunose; Koji Yamaguchi; Shusuke Yagi; Daiju Fukuda; Takashi Iwase; Hirotsugu Yamada; Tetsuzo Wakatsuki; Michio Shimabukuro; Naoki Muguruma; Tetsuji Takayama; Ichiro Kishimoto; Kenji Kangawa; Masataka Sata
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

Review 4.  Natriuretic Peptides: The Case of Prostate Cancer.

Authors:  Letizia Mezzasoma; Matthew J Peirce; Alba Minelli; Ilaria Bellezza
Journal:  Molecules       Date:  2017-10-10       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.